Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
Current Cancer Drug Targets
|
January 4, 2019
Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells
Yufeng Wu, Zhen He, Shaomei Li, et al.
Frontiers in Pharmacology
|
December 12, 2022
Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C <i>de novo</i> mutation: A case report
Jiuzhou Zhao, Xiang Li, Ruizhe Fan, et al.
International Journal of Molecular Medicine
|
November 3, 2018
Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
Dan Li, Gangcheng Wang, Guoguo Jin, et al.
BMC Cancer
|
April 12, 2025
Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy
Chengjuan Zhang, Tingjie Wang, Jing Yuan, et al.
Annals of Medicine
|
April 10, 2025
A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles
Yanping Hu, Bo Wang, Chao Shi, et al.
Translational Lung Cancer Research
|
March 15, 2021
Cell-free DNA from cerebrospinal fluid can be used to detect the <i>EGFR</i> mutation status of lung adenocarcinoma patients with central nervous system metastasis
Yang Liu, Sen Yang, Jiuzhou Zhao, et al.
Translational Lung Cancer Research
|
May 9, 2022
Clinicopathologic characteristics and diagnostic methods of <i>RET</i> rearrangement in Chinese non-small cell lung cancer patients
Junnan Feng, Yan Li, Bing Wei, et al.
Scientific Reports
|
August 8, 2025
Innovative diagnostic approaches for lung cancer: integrating traditional cytology with qPCR for rapid and reliable results
Ke Yang, Jiuzhou Zhao, Yanping Hu, et al.
Bioactive Materials
|
May 3, 2024
An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier
Zhen Li, Junyue Xing, Xiaohan Ma, et al.
Journal of Hazardous Materials
|
June 26, 2026
Overlooked dissemination risk of resistomes in mining soil environments
Li Tian, Jia-Nan Lu, Yun Zhang, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
Current Cancer Drug Targets
|
January 4, 2019
Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells
Yufeng Wu, Zhen He, Shaomei Li, et al.
Frontiers in Pharmacology
|
December 12, 2022
Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C <i>de novo</i> mutation: A case report
Jiuzhou Zhao, Xiang Li, Ruizhe Fan, et al.
International Journal of Molecular Medicine
|
November 3, 2018
Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
Dan Li, Gangcheng Wang, Guoguo Jin, et al.
BMC Cancer
|
April 12, 2025
Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy
Chengjuan Zhang, Tingjie Wang, Jing Yuan, et al.
Annals of Medicine
|
April 10, 2025
A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles
Yanping Hu, Bo Wang, Chao Shi, et al.
Translational Lung Cancer Research
|
March 15, 2021
Cell-free DNA from cerebrospinal fluid can be used to detect the <i>EGFR</i> mutation status of lung adenocarcinoma patients with central nervous system metastasis
Yang Liu, Sen Yang, Jiuzhou Zhao, et al.
Translational Lung Cancer Research
|
May 9, 2022
Clinicopathologic characteristics and diagnostic methods of <i>RET</i> rearrangement in Chinese non-small cell lung cancer patients
Junnan Feng, Yan Li, Bing Wei, et al.
Scientific Reports
|
August 8, 2025
Innovative diagnostic approaches for lung cancer: integrating traditional cytology with qPCR for rapid and reliable results
Ke Yang, Jiuzhou Zhao, Yanping Hu, et al.
Bioactive Materials
|
May 3, 2024
An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier
Zhen Li, Junyue Xing, Xiaohan Ma, et al.
Journal of Hazardous Materials
|
June 26, 2026
Overlooked dissemination risk of resistomes in mining soil environments
Li Tian, Jia-Nan Lu, Yun Zhang, et al.
Page
of 9